| Product Name | MF | CAS | Details |
|---|
| furo[2,3-d]pyrimidin-4-amine | C6H5N3O | 186454-70-6 | Details |
| 8-Oxa-3-azabicyclo[3.2.1]octane hydrochloride | C6H12ClNO | 54745-74-3 | Details |
| 2-chloropyrimidine-5-carbaldehyde | C5H3ClN2O | 933702-55-7 | Details |
| 6-bromo-1-chlorophthalazine | C8H4BrClN2 | 470484-70-9 | Details |
| 4-((tert-Butoxycarbonyl)ami)bicyclo[2.2.2]octane-1-carboxylic acid | C14H23NO4 | 863304-76-1 | Details |
| 2,5-diazabicyclo[2.2.2]octane-2-carboxylic acid tert-butyl ester | C11H20N2O2 | 858671-91-7 | Details |
| 1-Cyclopropyl-1,4-dihydro-6,8-dimethoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid | C22H27N3O5 | 1029364-73-5 | Details |
| cis-3,4-dihydroxypyrrolidine hydrochloride | C4H10ClNO2 | 186393-21-5 | Details |
| Dutasteride Impurity B | C27H30F6N2O2 | 957229-52-6 | Details |
| Obeticholic Acid Impurity 10 | C26H46O3 | 1537866-49-1 | Details |
| (1S,3R,4R)-2-azabicyclo[2.2.1]heptane-3-carboxylic acid | C7H11NO2 | 171754-03-3 | Details |
| Tolvaptan impurity | C10H10BrNO | 3951-89-1 | Details |
| 4-(Bromomethyl)tetrahydropyran | C6H11BrO | 125552-89-8 | Details |
| Obeticholic Acid Impurity 15 | Details |
| (3R)-3-[[(1S)-1-phenyl-3,4-dihydroisquinoline-2(1H)-carbonyl]oxy]-1-azabicyclo[2.2.2]octane 1-oxide(solifenacin N oxide) | C23H26N2O3 | 180272-28-0 | Details |
| Raltitrexed | C21H22N4O6S | 112887-68-0 | Details |
| 2-(Trimethylsilyl)ethoxymethyl chloride | C6H15ClOSi | 76513-69-4 | Details |
| tert-butyl N-[5-(4-methylbenzenesulfonyl)-5H-pyrrolo[2,3-b]pyrazin-2-yl]carbamate | C18H20N4O4S | 1201187-44-1 | Details |
| Obeticholic Acid Impurity 6 | C26H42O4 | Details |
| {bicyclo[2.2.2]octan-1-yl}methal | C9H16O | 2574-42-7 | Details |
| Obeticholic Acid Impurity 12 | Details |
| 1-(6-bromopyridin-3-yl)-4-(oxetan-3-yl)piperazine | C12H16BrN3O | Details |
| 6-methoxypyridazine-3-carboxylic acid | C6H6N2O3 | 56434-28-7 | Details |
| (3S)-1-azabicyclo[2.2.2]octan-3-yl(1S)-1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate | C27H32N2O6 | 862207-71-4 | Details |
| 2-bromo-1-(pyrimidin-2-yl)ethan-1-one hydrobromide | C6H6Br2N2O | 1588441-02-4 | Details |
| Trelagliptin Impurity 1 | C18H20FN5O2 | 2206135-35-3 | Details |
| Obeticholic Acid Impurity 8 | C26H42O4 | 915038-26-5 | Details |
| Obeticholic Acid Impurity 4 | C26H44O5 | 61800-60-0 | Details |
| Dutasteride Impurity E | C27H30F6N2O2 | 1796930-46-5 | Details |
| 2-acetamido-3-methyl-3-(nitrososulfanyl)butaic acid | C7H12N2O4S | 67776-06-1 | Details |
| 3-Quinolinecarboxylic acid, 1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-(octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-, (4aS-cis)- | C20H21F2N3O3 | 151213-15-9 | Details |
| tert-butyl (3R)-3-(amimethyl)pyrrolidine-1-carboxylate | C10H20N2O2 | 199174-29-3 | Details |
| methyl 4-amibicyclo[2.2.2]octane-1-carboxylate hydrochloride | C10H18ClNO2 | 135908-43-9 | Details |
| tert-Butyl 7-oxo-3-azabicyclo[3.3.1]nane-3-carboxylate | C13H21NO3 | 909135-31-5 | Details |
| ethyl 2-bromo-2-cyclopropylacetate | C7H11BrO2 | 1200828-74-5 | Details |
| (3R)-1-azabicyclo[2.2.2]octan-3-yl(1R)-1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate | C27H32N2O6 | 862207-70-3 | Details |
| imidazo[1,2-a]pyrazine-3-carboxylic acid | C7H5N3O2 | 1265896-03-4 | Details |
| (1S-CIS)-3-BROMO-3,5-CYCLOHEXADIENE-1,2-DIOL | C6H7BrO2 | 130792-45-9 | Details |
| Pyrimidine, 2-(chloromethyl)-5-methoxy-, hydrochloride | C6H7ClN2O | 1459748-96-9 | Details |
| 2-(Trimethylsilyl)ethanol | C5H14OSi | 2916-68-9 | Details |
| N-METHYLBARBITURIC ACID | C5H6N2O3 | 2565-47-1 | Details |
| N-{4-[(5RS)-7-Chloro-5-hydroxy-2,3,4,5-tetrahydro-1H-benzo[b]azepine-1-carbonyl]-3-methylphenyl}-2-methylbenzamide | C26H25ClN2O3 | 150683-30-0 | Details |
| Progesterone | C21H30O2 | 57-83-0 | Details |
| Obeticholic Acid Impurity 7 | Details |
| 5-bromo-2-(methoxymethyl)pyrimidine | C6H7BrN2O | 1476795-98-8 | Details |
| Dichloro-tert-butylmethylsilane | C5H12Cl2Si | 18147-18-7 | Details |
| Obeticholic Acid Impurity 13 | C28H46O5 | 2061908-14-1 | Details |
| 5-chloro-1H-pyrazolo[4,3-b]pyridine | C6H4ClN3 | 94220-45-8 | Details |
| Formalin; Methanal | CH2O | 50-00-0 | Details |
| 2-Acetylpyrimidine | C6H6N2O | 53342-27-1 | Details |
| methyl 4-{[(tert-butoxy)carbonyl]ami}bicyclo[2.2.2]octane-1-carboxylate | C15H25NO4 | 943845-74-7 | Details |
| Trelagliptin | C18H20FN5O2 | 865759-25-7 | Details |
| 3-bromo-6-chloropyrazine-2-carboxylic acid | C5H2BrClN2O2 | 1260773-60-1 | Details |
| Dutasteride Impurity C | C21H31NO3 | 157307-36-3 | Details |
| Obeticholic Acid Impurity 3 | Details |
| Trelagliptin Impurity 3 | Details |
| 4-chloro-5H,6H,7H-pyrrolo[3,4-d]pyrimidine hydrochloride | C6H7Cl2N3 | 1373228-90-0 | Details |
| Dichloromethylphenylsilane | C7H8Cl2Si | 149-74-6 | Details |
| 3-aminopiperidin-2-one; (+/-)-3-amino-piperidin-2-one; L-ornithine-δ-lactam;α-aminovalerolactam; (+/-)-3-amino-2-piperidone;3-amino-2-oxopiperidine; 3-amino-piperidin-2-one | C5H10N2O | 1892-22-4 | Details |
| endo-3-(Boc-ami)-8-azabicyclo[3.2.1]octane | C12H22N2O2 | 132234-69-6 | Details |
| 7-Boc-3-oxa-7,9-diazabicyclo[3.3.1]nonane | C11H20N2O3 | 864448-41-9 | Details |
| Obeticholic Acid Impurity 1 | Details |
| (S)-(+)-3-Quinuclidinol | C7H13NO | 34583-34-1 | Details |
| (1s,4s)-5-boc-2,5-diazabicyclo[2.2.1]heptane | C10H18N2O2 | 113451-59-5 | Details |
| 5-bromo-1H-pyrazolo[3,4-c]pyridine | C6H4BrN3 | 929617-35-6 | Details |
| 3-chlorooxetane | C3H5ClO | 4741-80-4 | Details |
| Nintedanib Impurity 1 | C31H33N5O4 | 656247-17-5 | Details |
| 5-bromoquiline-8-carbonitrile | C10H5BrN2 | 507476-70-2 | Details |
| (1R,3S,4S)-2-azabicyclo[2.2.1]heptane-3-carboxylic acid | C7H11NO2 | 171754-02-2 | Details |
| Dutasteride Impurity G | C27H28F6N2O2 | 1430804-85-5 | Details |
| [1,2,4]triazolo[4,3-b]pyridazine-6-carboxylic acid | C6H4N4O2 | 56434-29-8 | Details |
| 4-Pyrimidinecarboxylicacid,6-methyl-,methylester(9CI) | C7H8N2O2 | 73955-53-0 | Details |
| methyl bicyclo[2.2.2]octane-1-carboxylate | C11H18O2 | 31818-12-9 | Details |
| CIS-1,2-DIHYDROCATECHOL | C6H8O2 | 17793-95-2 | Details |
| Tiggio BCB Impurity | Details |
| Obeticholic Acid Impurity 9 | Details |
| 2-(chloromethyl)-5-fluoropyrimidine hydrochloride | C5H4ClFN2 | 1196151-61-7 | Details |
| Obeticholic Acid Impurity 14 | Details |
| (5-bromopyrimidin-2-yl)methal | C5H5BrN2O | 22433-12-1 | Details |
| bicyclo[2.2.2]octane-1-carboxylic acid | C9H14O2 | 699-55-8 | Details |
| (2R,4R)-4-fluoropyrrolidine-2-carboxylic acid hydrochloride | C5H9ClFNO2 | 1523541-82-3 | Details |
| (3S)-3-(4-hydroxyphenyl)hex-4-yic acid | C12H12O3 | 865233-35-8 | Details |
| methyl imidazo[1,2-a]pyrazine-3-carboxylate | C8H7N3O2 | 1206983-57-4 | Details |
| Obeticholic Acid Impurity 2 | Details |
| Obeticholic Acid Impurity 5 | C26H40O4 | 130081-08-2 | Details |
| 2-(aminomethyl)-4-fluorobenzonitrile | C8H7FN2 | 1243378-31-5 | Details |
| Obeticholic Acid Impurity 11 | Details |
| 3-oxo-4-aza-5α-androstane-17β-carboxylic acid | C19H29NO3 | 103335-55-3 | Details |
| Trelagliptin Impurity 2 | C18H21N5O2 | 850649-61-5 | Details |
| 3-bromoimidazo[1,2-a]pyrazine | C6H4BrN3 | 57948-41-1 | Details |
| Rivaroxaban | C19H18ClN3O5S | 366789-02-8 | Details |
| 1-(6-bromopyridin-3-yl)piperazine | C9H12BrN3 | 412347-39-8 | Details |
| (8-anti)-3-benzyl-3-azabicyclo[3.2.1]octan-8-ol | C14H19NO | 522608-86-2 | Details |
| Obeticholic Acid | C26H44O4 | 459789-99-2 | Details |
| Dutasteride Impurity D (Dutasteride 17-alfa-5-ene) | C27H31ClF6N2O2 | 1365545-42-1 | Details |
| (3S)-1-azabicyclo[2.2.2]octan-3-yl(1R)-1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate | C27H32N2O6 | 1262506-09-1 | Details |
| Nintedanib Impurity 4 | C31H32N6O6 | 2243396-74-7 | Details |
| 6-Chloro-3-methyluracil | C5H5ClN2O2 | 4318-56-3 | Details |
| methyl 3-bromobicyclo[1.1.1]pentane-1-carboxylate | C7H9BrO2 | 83249-14-3 | Details |
| 2-bromo-5-chloropyridine | C5H3BrClN | 40473-01-6 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 | ||||